Global Pharmaceutical Grade Poloxamer Market Growth 2026-2032
The global Pharmaceutical Grade Poloxamer market size is predicted to grow from US$ 144 million in 2025 to US$ 188 million in 2032; it is expected to grow at a CAGR of 3.9% from 2026 to 2032.
In 2025, global Pharmaceutical Grade Poloxamer production reached approximately 6,682 tons, with an average global market price of around US$22 per kilogram. Poloxamers are nonionic triblock copolymers composed of a central hydrophobic chain of polyoxypropylene (poly(propylene oxide)) flanked by two hydrophilic chains of polyoxyethylene (poly(ethylene oxide)). As well known solubilizers, pharmaceutical grade poloxamers are primarily employed to enhance solubility, absorption, and bioavailability of low-solubility actives. In addition to functioning as solubilizers, poloxamers can also be used as wetting agents, lubricants, or emulsifiers.
The global market for pharmaceutical grade Poloxamer is shaped by demand from biologic drugs and injectable formulations, with growth in the pharmaceutical excipients sector driving increased consumption. Shear protection in cell culture establishes Poloxamer 188 as a critical component in upstream biopharmaceutical processing, supporting the manufacturing of antibodies and gene therapies. Major suppliers provide cGMP-compliant grades that meet USP and EP standards. The Asia-Pacific region shows the strongest demand growth, driven by generic drug production and export expansion, while North America and Europe remain stable mature markets. Regulatory bodies such as the FDA and EMA continue to tighten purity and safety standards for excipients, raising entry barriers and reinforcing the preference for high-quality Poloxamer. Supply remains concentrated among a few established manufacturers with long-term expertise in block copolymer synthesis, making supply stability a key factor for global pharmaceutical supply chain security.
LP Information, Inc. (LPI) ' newest research report, the ?Pharmaceutical Grade Poloxamer Industry Forecast? looks at past sales and reviews total world Pharmaceutical Grade Poloxamer sales in 2025, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Grade Poloxamer sales for 2026 through 2032. With Pharmaceutical Grade Poloxamer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Grade Poloxamer industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Grade Poloxamer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Grade Poloxamer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Pharmaceutical Grade Poloxamer market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Grade Poloxamer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Grade Poloxamer.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Grade Poloxamer market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
In 2025, global Pharmaceutical Grade Poloxamer production reached approximately 6,682 tons, with an average global market price of around US$22 per kilogram. Poloxamers are nonionic triblock copolymers composed of a central hydrophobic chain of polyoxypropylene (poly(propylene oxide)) flanked by two hydrophilic chains of polyoxyethylene (poly(ethylene oxide)). As well known solubilizers, pharmaceutical grade poloxamers are primarily employed to enhance solubility, absorption, and bioavailability of low-solubility actives. In addition to functioning as solubilizers, poloxamers can also be used as wetting agents, lubricants, or emulsifiers.
The global market for pharmaceutical grade Poloxamer is shaped by demand from biologic drugs and injectable formulations, with growth in the pharmaceutical excipients sector driving increased consumption. Shear protection in cell culture establishes Poloxamer 188 as a critical component in upstream biopharmaceutical processing, supporting the manufacturing of antibodies and gene therapies. Major suppliers provide cGMP-compliant grades that meet USP and EP standards. The Asia-Pacific region shows the strongest demand growth, driven by generic drug production and export expansion, while North America and Europe remain stable mature markets. Regulatory bodies such as the FDA and EMA continue to tighten purity and safety standards for excipients, raising entry barriers and reinforcing the preference for high-quality Poloxamer. Supply remains concentrated among a few established manufacturers with long-term expertise in block copolymer synthesis, making supply stability a key factor for global pharmaceutical supply chain security.
LP Information, Inc. (LPI) ' newest research report, the ?Pharmaceutical Grade Poloxamer Industry Forecast? looks at past sales and reviews total world Pharmaceutical Grade Poloxamer sales in 2025, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Grade Poloxamer sales for 2026 through 2032. With Pharmaceutical Grade Poloxamer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Grade Poloxamer industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Grade Poloxamer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Grade Poloxamer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Pharmaceutical Grade Poloxamer market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Grade Poloxamer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Grade Poloxamer.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Grade Poloxamer market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Poloxamer 188
- Poloxamer 407
- Others
- ChP
- USP
- EP
- Others
- Solid
- Liquid
- Injectable Formulation
- Oral Formulation
- Topical Formulation
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- BASF
- Croda
- Syensqo
- Nanjing Well Pharmaceutical
- Hubei Hengshuo Chemical
- CD Formulation
- What is the 10-year outlook for the global Pharmaceutical Grade Poloxamer market?
- What factors are driving Pharmaceutical Grade Poloxamer market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How doPharmaceutical Grade Poloxamer market opportunities vary by end market size?
- How does Pharmaceutical Grade Poloxamer break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmaceutical Grade Poloxamer Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Pharmaceutical Grade Poloxamer by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Pharmaceutical Grade Poloxamer by Country/Region, 2021, 2025 & 2032
2.2 Pharmaceutical Grade Poloxamer Segment by Type
2.2.1 Poloxamer
2.2.2 Poloxamer
2.2.3 Others
2.2.4 Pharmaceutical Grade Poloxamer Sales by Type
2.2.4.1 Global Pharmaceutical Grade Poloxamer Sales Market Share by Type (2021-2026)
2.2.4.2 Global Pharmaceutical Grade Poloxamer Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Pharmaceutical Grade Poloxamer Sale Price by Type (2021-2026)
2.3 Pharmaceutical Grade Poloxamer Segment by Pharmacopoeia Standard
2.3.1 ChP
2.3.2 USP
2.3.3 EP
2.3.4 Others
2.3.5 Pharmaceutical Grade Poloxamer Sales by Pharmacopoeia Standard
2.3.5.1 Global Pharmaceutical Grade Poloxamer Sales Market Share by Pharmacopoeia Standard (2021-2026)
2.3.5.2 Global Pharmaceutical Grade Poloxamer Revenue and Market Share by Pharmacopoeia Standard (2021-2026)
2.3.5.3 Global Pharmaceutical Grade Poloxamer Sale Price by Pharmacopoeia Standard (2021-2026)
2.4 Pharmaceutical Grade Poloxamer Segment by Appearance
2.4.1 Solid
2.4.2 Liquid
2.4.3 Pharmaceutical Grade Poloxamer Sales by Appearance
2.4.3.1 Global Pharmaceutical Grade Poloxamer Sales Market Share by Appearance (2021-2026)
2.4.3.2 Global Pharmaceutical Grade Poloxamer Revenue and Market Share by Appearance (2021-2026)
2.4.3.3 Global Pharmaceutical Grade Poloxamer Sale Price by Appearance (2021-2026)
2.5 Pharmaceutical Grade Poloxamer Segment by Application
2.5.1 Injectable Formulation
2.5.2 Oral Formulation
2.5.3 Topical Formulation
2.5.4 Pharmaceutical Grade Poloxamer Sales by Application
2.5.4.1 Global Pharmaceutical Grade Poloxamer Sale Market Share by Application (2021-2026)
2.5.4.2 Global Pharmaceutical Grade Poloxamer Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Pharmaceutical Grade Poloxamer Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Pharmaceutical Grade Poloxamer Breakdown Data by Company
3.1.1 Global Pharmaceutical Grade Poloxamer Annual Sales by Company (2021-2026)
3.1.2 Global Pharmaceutical Grade Poloxamer Sales Market Share by Company (2021-2026)
3.2 Global Pharmaceutical Grade Poloxamer Annual Revenue by Company (2021-2026)
3.2.1 Global Pharmaceutical Grade Poloxamer Revenue by Company (2021-2026)
3.2.2 Global Pharmaceutical Grade Poloxamer Revenue Market Share by Company (2021-2026)
3.3 Global Pharmaceutical Grade Poloxamer Sale Price by Company
3.4 Key Manufacturers Pharmaceutical Grade Poloxamer Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pharmaceutical Grade Poloxamer Product Location Distribution
3.4.2 Players Pharmaceutical Grade Poloxamer Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PHARMACEUTICAL GRADE POLOXAMER BY GEOGRAPHIC REGION
4.1 World Historic Pharmaceutical Grade Poloxamer Market Size by Geographic Region (2021-2026)
4.1.1 Global Pharmaceutical Grade Poloxamer Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Pharmaceutical Grade Poloxamer Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Pharmaceutical Grade Poloxamer Market Size by Country/Region (2021-2026)
4.2.1 Global Pharmaceutical Grade Poloxamer Annual Sales by Country/Region (2021-2026)
4.2.2 Global Pharmaceutical Grade Poloxamer Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pharmaceutical Grade Poloxamer Sales Growth
4.4 APAC Pharmaceutical Grade Poloxamer Sales Growth
4.5 Europe Pharmaceutical Grade Poloxamer Sales Growth
4.6 Middle East & Africa Pharmaceutical Grade Poloxamer Sales Growth
5 AMERICAS
5.1 Americas Pharmaceutical Grade Poloxamer Sales by Country
5.1.1 Americas Pharmaceutical Grade Poloxamer Sales by Country (2021-2026)
5.1.2 Americas Pharmaceutical Grade Poloxamer Revenue by Country (2021-2026)
5.2 Americas Pharmaceutical Grade Poloxamer Sales by Type (2021-2026)
5.3 Americas Pharmaceutical Grade Poloxamer Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Grade Poloxamer Sales by Region
6.1.1 APAC Pharmaceutical Grade Poloxamer Sales by Region (2021-2026)
6.1.2 APAC Pharmaceutical Grade Poloxamer Revenue by Region (2021-2026)
6.2 APAC Pharmaceutical Grade Poloxamer Sales by Type (2021-2026)
6.3 APAC Pharmaceutical Grade Poloxamer Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pharmaceutical Grade Poloxamer by Country
7.1.1 Europe Pharmaceutical Grade Poloxamer Sales by Country (2021-2026)
7.1.2 Europe Pharmaceutical Grade Poloxamer Revenue by Country (2021-2026)
7.2 Europe Pharmaceutical Grade Poloxamer Sales by Type (2021-2026)
7.3 Europe Pharmaceutical Grade Poloxamer Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmaceutical Grade Poloxamer by Country
8.1.1 Middle East & Africa Pharmaceutical Grade Poloxamer Sales by Country (2021-2026)
8.1.2 Middle East & Africa Pharmaceutical Grade Poloxamer Revenue by Country (2021-2026)
8.2 Middle East & Africa Pharmaceutical Grade Poloxamer Sales by Type (2021-2026)
8.3 Middle East & Africa Pharmaceutical Grade Poloxamer Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pharmaceutical Grade Poloxamer
10.3 Manufacturing Process Analysis of Pharmaceutical Grade Poloxamer
10.4 Industry Chain Structure of Pharmaceutical Grade Poloxamer
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pharmaceutical Grade Poloxamer Distributors
11.3 Pharmaceutical Grade Poloxamer Customer
12 WORLD FORECAST REVIEW FOR PHARMACEUTICAL GRADE POLOXAMER BY GEOGRAPHIC REGION
12.1 Global Pharmaceutical Grade Poloxamer Market Size Forecast by Region
12.1.1 Global Pharmaceutical Grade Poloxamer Forecast by Region (2027-2032)
12.1.2 Global Pharmaceutical Grade Poloxamer Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Pharmaceutical Grade Poloxamer Forecast by Type (2027-2032)
12.7 Global Pharmaceutical Grade Poloxamer Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 BASF
13.1.1 BASF Company Information
13.1.2 BASF Pharmaceutical Grade Poloxamer Product Portfolios and Specifications
13.1.3 BASF Pharmaceutical Grade Poloxamer Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 BASF Main Business Overview
13.1.5 BASF Latest Developments
13.2 Croda
13.2.1 Croda Company Information
13.2.2 Croda Pharmaceutical Grade Poloxamer Product Portfolios and Specifications
13.2.3 Croda Pharmaceutical Grade Poloxamer Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Croda Main Business Overview
13.2.5 Croda Latest Developments
13.3 Syensqo
13.3.1 Syensqo Company Information
13.3.2 Syensqo Pharmaceutical Grade Poloxamer Product Portfolios and Specifications
13.3.3 Syensqo Pharmaceutical Grade Poloxamer Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Syensqo Main Business Overview
13.3.5 Syensqo Latest Developments
13.4 Nanjing Well Pharmaceutical
13.4.1 Nanjing Well Pharmaceutical Company Information
13.4.2 Nanjing Well Pharmaceutical Pharmaceutical Grade Poloxamer Product Portfolios and Specifications
13.4.3 Nanjing Well Pharmaceutical Pharmaceutical Grade Poloxamer Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Nanjing Well Pharmaceutical Main Business Overview
13.4.5 Nanjing Well Pharmaceutical Latest Developments
13.5 Hubei Hengshuo Chemical
13.5.1 Hubei Hengshuo Chemical Company Information
13.5.2 Hubei Hengshuo Chemical Pharmaceutical Grade Poloxamer Product Portfolios and Specifications
13.5.3 Hubei Hengshuo Chemical Pharmaceutical Grade Poloxamer Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Hubei Hengshuo Chemical Main Business Overview
13.5.5 Hubei Hengshuo Chemical Latest Developments
13.6 CD Formulation
13.6.1 CD Formulation Company Information
13.6.2 CD Formulation Pharmaceutical Grade Poloxamer Product Portfolios and Specifications
13.6.3 CD Formulation Pharmaceutical Grade Poloxamer Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 CD Formulation Main Business Overview
13.6.5 CD Formulation Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmaceutical Grade Poloxamer Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Pharmaceutical Grade Poloxamer by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Pharmaceutical Grade Poloxamer by Country/Region, 2021, 2025 & 2032
2.2 Pharmaceutical Grade Poloxamer Segment by Type
2.2.1 Poloxamer
2.2.2 Poloxamer
2.2.3 Others
2.2.4 Pharmaceutical Grade Poloxamer Sales by Type
2.2.4.1 Global Pharmaceutical Grade Poloxamer Sales Market Share by Type (2021-2026)
2.2.4.2 Global Pharmaceutical Grade Poloxamer Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Pharmaceutical Grade Poloxamer Sale Price by Type (2021-2026)
2.3 Pharmaceutical Grade Poloxamer Segment by Pharmacopoeia Standard
2.3.1 ChP
2.3.2 USP
2.3.3 EP
2.3.4 Others
2.3.5 Pharmaceutical Grade Poloxamer Sales by Pharmacopoeia Standard
2.3.5.1 Global Pharmaceutical Grade Poloxamer Sales Market Share by Pharmacopoeia Standard (2021-2026)
2.3.5.2 Global Pharmaceutical Grade Poloxamer Revenue and Market Share by Pharmacopoeia Standard (2021-2026)
2.3.5.3 Global Pharmaceutical Grade Poloxamer Sale Price by Pharmacopoeia Standard (2021-2026)
2.4 Pharmaceutical Grade Poloxamer Segment by Appearance
2.4.1 Solid
2.4.2 Liquid
2.4.3 Pharmaceutical Grade Poloxamer Sales by Appearance
2.4.3.1 Global Pharmaceutical Grade Poloxamer Sales Market Share by Appearance (2021-2026)
2.4.3.2 Global Pharmaceutical Grade Poloxamer Revenue and Market Share by Appearance (2021-2026)
2.4.3.3 Global Pharmaceutical Grade Poloxamer Sale Price by Appearance (2021-2026)
2.5 Pharmaceutical Grade Poloxamer Segment by Application
2.5.1 Injectable Formulation
2.5.2 Oral Formulation
2.5.3 Topical Formulation
2.5.4 Pharmaceutical Grade Poloxamer Sales by Application
2.5.4.1 Global Pharmaceutical Grade Poloxamer Sale Market Share by Application (2021-2026)
2.5.4.2 Global Pharmaceutical Grade Poloxamer Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Pharmaceutical Grade Poloxamer Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Pharmaceutical Grade Poloxamer Breakdown Data by Company
3.1.1 Global Pharmaceutical Grade Poloxamer Annual Sales by Company (2021-2026)
3.1.2 Global Pharmaceutical Grade Poloxamer Sales Market Share by Company (2021-2026)
3.2 Global Pharmaceutical Grade Poloxamer Annual Revenue by Company (2021-2026)
3.2.1 Global Pharmaceutical Grade Poloxamer Revenue by Company (2021-2026)
3.2.2 Global Pharmaceutical Grade Poloxamer Revenue Market Share by Company (2021-2026)
3.3 Global Pharmaceutical Grade Poloxamer Sale Price by Company
3.4 Key Manufacturers Pharmaceutical Grade Poloxamer Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pharmaceutical Grade Poloxamer Product Location Distribution
3.4.2 Players Pharmaceutical Grade Poloxamer Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PHARMACEUTICAL GRADE POLOXAMER BY GEOGRAPHIC REGION
4.1 World Historic Pharmaceutical Grade Poloxamer Market Size by Geographic Region (2021-2026)
4.1.1 Global Pharmaceutical Grade Poloxamer Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Pharmaceutical Grade Poloxamer Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Pharmaceutical Grade Poloxamer Market Size by Country/Region (2021-2026)
4.2.1 Global Pharmaceutical Grade Poloxamer Annual Sales by Country/Region (2021-2026)
4.2.2 Global Pharmaceutical Grade Poloxamer Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pharmaceutical Grade Poloxamer Sales Growth
4.4 APAC Pharmaceutical Grade Poloxamer Sales Growth
4.5 Europe Pharmaceutical Grade Poloxamer Sales Growth
4.6 Middle East & Africa Pharmaceutical Grade Poloxamer Sales Growth
5 AMERICAS
5.1 Americas Pharmaceutical Grade Poloxamer Sales by Country
5.1.1 Americas Pharmaceutical Grade Poloxamer Sales by Country (2021-2026)
5.1.2 Americas Pharmaceutical Grade Poloxamer Revenue by Country (2021-2026)
5.2 Americas Pharmaceutical Grade Poloxamer Sales by Type (2021-2026)
5.3 Americas Pharmaceutical Grade Poloxamer Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Grade Poloxamer Sales by Region
6.1.1 APAC Pharmaceutical Grade Poloxamer Sales by Region (2021-2026)
6.1.2 APAC Pharmaceutical Grade Poloxamer Revenue by Region (2021-2026)
6.2 APAC Pharmaceutical Grade Poloxamer Sales by Type (2021-2026)
6.3 APAC Pharmaceutical Grade Poloxamer Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pharmaceutical Grade Poloxamer by Country
7.1.1 Europe Pharmaceutical Grade Poloxamer Sales by Country (2021-2026)
7.1.2 Europe Pharmaceutical Grade Poloxamer Revenue by Country (2021-2026)
7.2 Europe Pharmaceutical Grade Poloxamer Sales by Type (2021-2026)
7.3 Europe Pharmaceutical Grade Poloxamer Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmaceutical Grade Poloxamer by Country
8.1.1 Middle East & Africa Pharmaceutical Grade Poloxamer Sales by Country (2021-2026)
8.1.2 Middle East & Africa Pharmaceutical Grade Poloxamer Revenue by Country (2021-2026)
8.2 Middle East & Africa Pharmaceutical Grade Poloxamer Sales by Type (2021-2026)
8.3 Middle East & Africa Pharmaceutical Grade Poloxamer Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pharmaceutical Grade Poloxamer
10.3 Manufacturing Process Analysis of Pharmaceutical Grade Poloxamer
10.4 Industry Chain Structure of Pharmaceutical Grade Poloxamer
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pharmaceutical Grade Poloxamer Distributors
11.3 Pharmaceutical Grade Poloxamer Customer
12 WORLD FORECAST REVIEW FOR PHARMACEUTICAL GRADE POLOXAMER BY GEOGRAPHIC REGION
12.1 Global Pharmaceutical Grade Poloxamer Market Size Forecast by Region
12.1.1 Global Pharmaceutical Grade Poloxamer Forecast by Region (2027-2032)
12.1.2 Global Pharmaceutical Grade Poloxamer Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Pharmaceutical Grade Poloxamer Forecast by Type (2027-2032)
12.7 Global Pharmaceutical Grade Poloxamer Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 BASF
13.1.1 BASF Company Information
13.1.2 BASF Pharmaceutical Grade Poloxamer Product Portfolios and Specifications
13.1.3 BASF Pharmaceutical Grade Poloxamer Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 BASF Main Business Overview
13.1.5 BASF Latest Developments
13.2 Croda
13.2.1 Croda Company Information
13.2.2 Croda Pharmaceutical Grade Poloxamer Product Portfolios and Specifications
13.2.3 Croda Pharmaceutical Grade Poloxamer Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Croda Main Business Overview
13.2.5 Croda Latest Developments
13.3 Syensqo
13.3.1 Syensqo Company Information
13.3.2 Syensqo Pharmaceutical Grade Poloxamer Product Portfolios and Specifications
13.3.3 Syensqo Pharmaceutical Grade Poloxamer Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Syensqo Main Business Overview
13.3.5 Syensqo Latest Developments
13.4 Nanjing Well Pharmaceutical
13.4.1 Nanjing Well Pharmaceutical Company Information
13.4.2 Nanjing Well Pharmaceutical Pharmaceutical Grade Poloxamer Product Portfolios and Specifications
13.4.3 Nanjing Well Pharmaceutical Pharmaceutical Grade Poloxamer Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Nanjing Well Pharmaceutical Main Business Overview
13.4.5 Nanjing Well Pharmaceutical Latest Developments
13.5 Hubei Hengshuo Chemical
13.5.1 Hubei Hengshuo Chemical Company Information
13.5.2 Hubei Hengshuo Chemical Pharmaceutical Grade Poloxamer Product Portfolios and Specifications
13.5.3 Hubei Hengshuo Chemical Pharmaceutical Grade Poloxamer Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Hubei Hengshuo Chemical Main Business Overview
13.5.5 Hubei Hengshuo Chemical Latest Developments
13.6 CD Formulation
13.6.1 CD Formulation Company Information
13.6.2 CD Formulation Pharmaceutical Grade Poloxamer Product Portfolios and Specifications
13.6.3 CD Formulation Pharmaceutical Grade Poloxamer Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 CD Formulation Main Business Overview
13.6.5 CD Formulation Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pharmaceutical Grade Poloxamer Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Pharmaceutical Grade Poloxamer Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Poloxamer 188
Table 4. Major Players of Poloxamer 407
Table 5. Major Players of Others
Table 6. Global Pharmaceutical Grade Poloxamer Sales by Type (2021-2026) & (Tons)
Table 7. Global Pharmaceutical Grade Poloxamer Sales Market Share by Type (2021-2026)
Table 8. Global Pharmaceutical Grade Poloxamer Revenue by Type (2021-2026) & ($ million)
Table 9. Global Pharmaceutical Grade Poloxamer Revenue Market Share by Type (2021-2026)
Table 10. Global Pharmaceutical Grade Poloxamer Sale Price by Type (2021-2026) & (US$/Kg)
Table 11. Major Players of ChP
Table 12. Major Players of USP
Table 13. Major Players of EP
Table 14. Major Players of Others
Table 15. Global Pharmaceutical Grade Poloxamer Sales by Pharmacopoeia Standard (2021-2026) & (Tons)
Table 16. Global Pharmaceutical Grade Poloxamer Sales Market Share by Pharmacopoeia Standard (2021-2026)
Table 17. Global Pharmaceutical Grade Poloxamer Revenue by Pharmacopoeia Standard (2021-2026) & ($ million)
Table 18. Global Pharmaceutical Grade Poloxamer Revenue Market Share by Pharmacopoeia Standard (2021-2026)
Table 19. Global Pharmaceutical Grade Poloxamer Sale Price by Pharmacopoeia Standard (2021-2026) & (US$/Kg)
Table 20. Major Players of Solid
Table 21. Major Players of Liquid
Table 22. Global Pharmaceutical Grade Poloxamer Sales by Appearance (2021-2026) & (Tons)
Table 23. Global Pharmaceutical Grade Poloxamer Sales Market Share by Appearance (2021-2026)
Table 24. Global Pharmaceutical Grade Poloxamer Revenue by Appearance (2021-2026) & ($ million)
Table 25. Global Pharmaceutical Grade Poloxamer Revenue Market Share by Appearance (2021-2026)
Table 26. Global Pharmaceutical Grade Poloxamer Sale Price by Appearance (2021-2026) & (US$/Kg)
Table 27. Global Pharmaceutical Grade Poloxamer Sale by Application (2021-2026) & (Tons)
Table 28. Global Pharmaceutical Grade Poloxamer Sale Market Share by Application (2021-2026)
Table 29. Global Pharmaceutical Grade Poloxamer Revenue by Application (2021-2026) & ($ million)
Table 30. Global Pharmaceutical Grade Poloxamer Revenue Market Share by Application (2021-2026)
Table 31. Global Pharmaceutical Grade Poloxamer Sale Price by Application (2021-2026) & (US$/Kg)
Table 32. Global Pharmaceutical Grade Poloxamer Sales by Company (2021-2026) & (Tons)
Table 33. Global Pharmaceutical Grade Poloxamer Sales Market Share by Company (2021-2026)
Table 34. Global Pharmaceutical Grade Poloxamer Revenue by Company (2021-2026) & ($ millions)
Table 35. Global Pharmaceutical Grade Poloxamer Revenue Market Share by Company (2021-2026)
Table 36. Global Pharmaceutical Grade Poloxamer Sale Price by Company (2021-2026) & (US$/Kg)
Table 37. Key Manufacturers Pharmaceutical Grade Poloxamer Producing Area Distribution and Sales Area
Table 38. Players Pharmaceutical Grade Poloxamer Products Offered
Table 39. Pharmaceutical Grade Poloxamer Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global Pharmaceutical Grade Poloxamer Sales by Geographic Region (2021-2026) & (Tons)
Table 43. Global Pharmaceutical Grade Poloxamer Sales Market Share Geographic Region (2021-2026)
Table 44. Global Pharmaceutical Grade Poloxamer Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global Pharmaceutical Grade Poloxamer Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global Pharmaceutical Grade Poloxamer Sales by Country/Region (2021-2026) & (Tons)
Table 47. Global Pharmaceutical Grade Poloxamer Sales Market Share by Country/Region (2021-2026)
Table 48. Global Pharmaceutical Grade Poloxamer Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global Pharmaceutical Grade Poloxamer Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas Pharmaceutical Grade Poloxamer Sales by Country (2021-2026) & (Tons)
Table 51. Americas Pharmaceutical Grade Poloxamer Sales Market Share by Country (2021-2026)
Table 52. Americas Pharmaceutical Grade Poloxamer Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas Pharmaceutical Grade Poloxamer Sales by Type (2021-2026) & (Tons)
Table 54. Americas Pharmaceutical Grade Poloxamer Sales by Application (2021-2026) & (Tons)
Table 55. APAC Pharmaceutical Grade Poloxamer Sales by Region (2021-2026) & (Tons)
Table 56. APAC Pharmaceutical Grade Poloxamer Sales Market Share by Region (2021-2026)
Table 57. APAC Pharmaceutical Grade Poloxamer Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC Pharmaceutical Grade Poloxamer Sales by Type (2021-2026) & (Tons)
Table 59. APAC Pharmaceutical Grade Poloxamer Sales by Application (2021-2026) & (Tons)
Table 60. Europe Pharmaceutical Grade Poloxamer Sales by Country (2021-2026) & (Tons)
Table 61. Europe Pharmaceutical Grade Poloxamer Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe Pharmaceutical Grade Poloxamer Sales by Type (2021-2026) & (Tons)
Table 63. Europe Pharmaceutical Grade Poloxamer Sales by Application (2021-2026) & (Tons)
Table 64. Middle East & Africa Pharmaceutical Grade Poloxamer Sales by Country (2021-2026) & (Tons)
Table 65. Middle East & Africa Pharmaceutical Grade Poloxamer Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa Pharmaceutical Grade Poloxamer Sales by Type (2021-2026) & (Tons)
Table 67. Middle East & Africa Pharmaceutical Grade Poloxamer Sales by Application (2021-2026) & (Tons)
Table 68. Key Market Drivers & Growth Opportunities of Pharmaceutical Grade Poloxamer
Table 69. Key Market Challenges & Risks of Pharmaceutical Grade Poloxamer
Table 70. Key Industry Trends of Pharmaceutical Grade Poloxamer
Table 71. Pharmaceutical Grade Poloxamer Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Pharmaceutical Grade Poloxamer Distributors List
Table 74. Pharmaceutical Grade Poloxamer Customer List
Table 75. Global Pharmaceutical Grade Poloxamer Sales Forecast by Region (2027-2032) & (Tons)
Table 76. Global Pharmaceutical Grade Poloxamer Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas Pharmaceutical Grade Poloxamer Sales Forecast by Country (2027-2032) & (Tons)
Table 78. Americas Pharmaceutical Grade Poloxamer Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC Pharmaceutical Grade Poloxamer Sales Forecast by Region (2027-2032) & (Tons)
Table 80. APAC Pharmaceutical Grade Poloxamer Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe Pharmaceutical Grade Poloxamer Sales Forecast by Country (2027-2032) & (Tons)
Table 82. Europe Pharmaceutical Grade Poloxamer Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa Pharmaceutical Grade Poloxamer Sales Forecast by Country (2027-2032) & (Tons)
Table 84. Middle East & Africa Pharmaceutical Grade Poloxamer Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global Pharmaceutical Grade Poloxamer Sales Forecast by Type (2027-2032) & (Tons)
Table 86. Global Pharmaceutical Grade Poloxamer Revenue Forecast by Type (2027-2032) & ($ millions)
Table 87. Global Pharmaceutical Grade Poloxamer Sales Forecast by Application (2027-2032) & (Tons)
Table 88. Global Pharmaceutical Grade Poloxamer Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. BASF Basic Information, Pharmaceutical Grade Poloxamer Manufacturing Base, Sales Area and Its Competitors
Table 90. BASF Pharmaceutical Grade Poloxamer Product Portfolios and Specifications
Table 91. BASF Pharmaceutical Grade Poloxamer Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 92. BASF Main Business
Table 93. BASF Latest Developments
Table 94. Croda Basic Information, Pharmaceutical Grade Poloxamer Manufacturing Base, Sales Area and Its Competitors
Table 95. Croda Pharmaceutical Grade Poloxamer Product Portfolios and Specifications
Table 96. Croda Pharmaceutical Grade Poloxamer Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 97. Croda Main Business
Table 98. Croda Latest Developments
Table 99. Syensqo Basic Information, Pharmaceutical Grade Poloxamer Manufacturing Base, Sales Area and Its Competitors
Table 100. Syensqo Pharmaceutical Grade Poloxamer Product Portfolios and Specifications
Table 101. Syensqo Pharmaceutical Grade Poloxamer Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 102. Syensqo Main Business
Table 103. Syensqo Latest Developments
Table 104. Nanjing Well Pharmaceutical Basic Information, Pharmaceutical Grade Poloxamer Manufacturing Base, Sales Area and Its Competitors
Table 105. Nanjing Well Pharmaceutical Pharmaceutical Grade Poloxamer Product Portfolios and Specifications
Table 106. Nanjing Well Pharmaceutical Pharmaceutical Grade Poloxamer Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 107. Nanjing Well Pharmaceutical Main Business
Table 108. Nanjing Well Pharmaceutical Latest Developments
Table 109. Hubei Hengshuo Chemical Basic Information, Pharmaceutical Grade Poloxamer Manufacturing Base, Sales Area and Its Competitors
Table 110. Hubei Hengshuo Chemical Pharmaceutical Grade Poloxamer Product Portfolios and Specifications
Table 111. Hubei Hengshuo Chemical Pharmaceutical Grade Poloxamer Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 112. Hubei Hengshuo Chemical Main Business
Table 113. Hubei Hengshuo Chemical Latest Developments
Table 114. CD Formulation Basic Information, Pharmaceutical Grade Poloxamer Manufacturing Base, Sales Area and Its Competitors
Table 115. CD Formulation Pharmaceutical Grade Poloxamer Product Portfolios and Specifications
Table 116. CD Formulation Pharmaceutical Grade Poloxamer Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 117. CD Formulation Main Business
Table 118. CD Formulation Latest Developments
Table 1. Pharmaceutical Grade Poloxamer Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Pharmaceutical Grade Poloxamer Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Poloxamer 188
Table 4. Major Players of Poloxamer 407
Table 5. Major Players of Others
Table 6. Global Pharmaceutical Grade Poloxamer Sales by Type (2021-2026) & (Tons)
Table 7. Global Pharmaceutical Grade Poloxamer Sales Market Share by Type (2021-2026)
Table 8. Global Pharmaceutical Grade Poloxamer Revenue by Type (2021-2026) & ($ million)
Table 9. Global Pharmaceutical Grade Poloxamer Revenue Market Share by Type (2021-2026)
Table 10. Global Pharmaceutical Grade Poloxamer Sale Price by Type (2021-2026) & (US$/Kg)
Table 11. Major Players of ChP
Table 12. Major Players of USP
Table 13. Major Players of EP
Table 14. Major Players of Others
Table 15. Global Pharmaceutical Grade Poloxamer Sales by Pharmacopoeia Standard (2021-2026) & (Tons)
Table 16. Global Pharmaceutical Grade Poloxamer Sales Market Share by Pharmacopoeia Standard (2021-2026)
Table 17. Global Pharmaceutical Grade Poloxamer Revenue by Pharmacopoeia Standard (2021-2026) & ($ million)
Table 18. Global Pharmaceutical Grade Poloxamer Revenue Market Share by Pharmacopoeia Standard (2021-2026)
Table 19. Global Pharmaceutical Grade Poloxamer Sale Price by Pharmacopoeia Standard (2021-2026) & (US$/Kg)
Table 20. Major Players of Solid
Table 21. Major Players of Liquid
Table 22. Global Pharmaceutical Grade Poloxamer Sales by Appearance (2021-2026) & (Tons)
Table 23. Global Pharmaceutical Grade Poloxamer Sales Market Share by Appearance (2021-2026)
Table 24. Global Pharmaceutical Grade Poloxamer Revenue by Appearance (2021-2026) & ($ million)
Table 25. Global Pharmaceutical Grade Poloxamer Revenue Market Share by Appearance (2021-2026)
Table 26. Global Pharmaceutical Grade Poloxamer Sale Price by Appearance (2021-2026) & (US$/Kg)
Table 27. Global Pharmaceutical Grade Poloxamer Sale by Application (2021-2026) & (Tons)
Table 28. Global Pharmaceutical Grade Poloxamer Sale Market Share by Application (2021-2026)
Table 29. Global Pharmaceutical Grade Poloxamer Revenue by Application (2021-2026) & ($ million)
Table 30. Global Pharmaceutical Grade Poloxamer Revenue Market Share by Application (2021-2026)
Table 31. Global Pharmaceutical Grade Poloxamer Sale Price by Application (2021-2026) & (US$/Kg)
Table 32. Global Pharmaceutical Grade Poloxamer Sales by Company (2021-2026) & (Tons)
Table 33. Global Pharmaceutical Grade Poloxamer Sales Market Share by Company (2021-2026)
Table 34. Global Pharmaceutical Grade Poloxamer Revenue by Company (2021-2026) & ($ millions)
Table 35. Global Pharmaceutical Grade Poloxamer Revenue Market Share by Company (2021-2026)
Table 36. Global Pharmaceutical Grade Poloxamer Sale Price by Company (2021-2026) & (US$/Kg)
Table 37. Key Manufacturers Pharmaceutical Grade Poloxamer Producing Area Distribution and Sales Area
Table 38. Players Pharmaceutical Grade Poloxamer Products Offered
Table 39. Pharmaceutical Grade Poloxamer Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global Pharmaceutical Grade Poloxamer Sales by Geographic Region (2021-2026) & (Tons)
Table 43. Global Pharmaceutical Grade Poloxamer Sales Market Share Geographic Region (2021-2026)
Table 44. Global Pharmaceutical Grade Poloxamer Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global Pharmaceutical Grade Poloxamer Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global Pharmaceutical Grade Poloxamer Sales by Country/Region (2021-2026) & (Tons)
Table 47. Global Pharmaceutical Grade Poloxamer Sales Market Share by Country/Region (2021-2026)
Table 48. Global Pharmaceutical Grade Poloxamer Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global Pharmaceutical Grade Poloxamer Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas Pharmaceutical Grade Poloxamer Sales by Country (2021-2026) & (Tons)
Table 51. Americas Pharmaceutical Grade Poloxamer Sales Market Share by Country (2021-2026)
Table 52. Americas Pharmaceutical Grade Poloxamer Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas Pharmaceutical Grade Poloxamer Sales by Type (2021-2026) & (Tons)
Table 54. Americas Pharmaceutical Grade Poloxamer Sales by Application (2021-2026) & (Tons)
Table 55. APAC Pharmaceutical Grade Poloxamer Sales by Region (2021-2026) & (Tons)
Table 56. APAC Pharmaceutical Grade Poloxamer Sales Market Share by Region (2021-2026)
Table 57. APAC Pharmaceutical Grade Poloxamer Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC Pharmaceutical Grade Poloxamer Sales by Type (2021-2026) & (Tons)
Table 59. APAC Pharmaceutical Grade Poloxamer Sales by Application (2021-2026) & (Tons)
Table 60. Europe Pharmaceutical Grade Poloxamer Sales by Country (2021-2026) & (Tons)
Table 61. Europe Pharmaceutical Grade Poloxamer Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe Pharmaceutical Grade Poloxamer Sales by Type (2021-2026) & (Tons)
Table 63. Europe Pharmaceutical Grade Poloxamer Sales by Application (2021-2026) & (Tons)
Table 64. Middle East & Africa Pharmaceutical Grade Poloxamer Sales by Country (2021-2026) & (Tons)
Table 65. Middle East & Africa Pharmaceutical Grade Poloxamer Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa Pharmaceutical Grade Poloxamer Sales by Type (2021-2026) & (Tons)
Table 67. Middle East & Africa Pharmaceutical Grade Poloxamer Sales by Application (2021-2026) & (Tons)
Table 68. Key Market Drivers & Growth Opportunities of Pharmaceutical Grade Poloxamer
Table 69. Key Market Challenges & Risks of Pharmaceutical Grade Poloxamer
Table 70. Key Industry Trends of Pharmaceutical Grade Poloxamer
Table 71. Pharmaceutical Grade Poloxamer Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Pharmaceutical Grade Poloxamer Distributors List
Table 74. Pharmaceutical Grade Poloxamer Customer List
Table 75. Global Pharmaceutical Grade Poloxamer Sales Forecast by Region (2027-2032) & (Tons)
Table 76. Global Pharmaceutical Grade Poloxamer Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas Pharmaceutical Grade Poloxamer Sales Forecast by Country (2027-2032) & (Tons)
Table 78. Americas Pharmaceutical Grade Poloxamer Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC Pharmaceutical Grade Poloxamer Sales Forecast by Region (2027-2032) & (Tons)
Table 80. APAC Pharmaceutical Grade Poloxamer Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe Pharmaceutical Grade Poloxamer Sales Forecast by Country (2027-2032) & (Tons)
Table 82. Europe Pharmaceutical Grade Poloxamer Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa Pharmaceutical Grade Poloxamer Sales Forecast by Country (2027-2032) & (Tons)
Table 84. Middle East & Africa Pharmaceutical Grade Poloxamer Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global Pharmaceutical Grade Poloxamer Sales Forecast by Type (2027-2032) & (Tons)
Table 86. Global Pharmaceutical Grade Poloxamer Revenue Forecast by Type (2027-2032) & ($ millions)
Table 87. Global Pharmaceutical Grade Poloxamer Sales Forecast by Application (2027-2032) & (Tons)
Table 88. Global Pharmaceutical Grade Poloxamer Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. BASF Basic Information, Pharmaceutical Grade Poloxamer Manufacturing Base, Sales Area and Its Competitors
Table 90. BASF Pharmaceutical Grade Poloxamer Product Portfolios and Specifications
Table 91. BASF Pharmaceutical Grade Poloxamer Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 92. BASF Main Business
Table 93. BASF Latest Developments
Table 94. Croda Basic Information, Pharmaceutical Grade Poloxamer Manufacturing Base, Sales Area and Its Competitors
Table 95. Croda Pharmaceutical Grade Poloxamer Product Portfolios and Specifications
Table 96. Croda Pharmaceutical Grade Poloxamer Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 97. Croda Main Business
Table 98. Croda Latest Developments
Table 99. Syensqo Basic Information, Pharmaceutical Grade Poloxamer Manufacturing Base, Sales Area and Its Competitors
Table 100. Syensqo Pharmaceutical Grade Poloxamer Product Portfolios and Specifications
Table 101. Syensqo Pharmaceutical Grade Poloxamer Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 102. Syensqo Main Business
Table 103. Syensqo Latest Developments
Table 104. Nanjing Well Pharmaceutical Basic Information, Pharmaceutical Grade Poloxamer Manufacturing Base, Sales Area and Its Competitors
Table 105. Nanjing Well Pharmaceutical Pharmaceutical Grade Poloxamer Product Portfolios and Specifications
Table 106. Nanjing Well Pharmaceutical Pharmaceutical Grade Poloxamer Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 107. Nanjing Well Pharmaceutical Main Business
Table 108. Nanjing Well Pharmaceutical Latest Developments
Table 109. Hubei Hengshuo Chemical Basic Information, Pharmaceutical Grade Poloxamer Manufacturing Base, Sales Area and Its Competitors
Table 110. Hubei Hengshuo Chemical Pharmaceutical Grade Poloxamer Product Portfolios and Specifications
Table 111. Hubei Hengshuo Chemical Pharmaceutical Grade Poloxamer Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 112. Hubei Hengshuo Chemical Main Business
Table 113. Hubei Hengshuo Chemical Latest Developments
Table 114. CD Formulation Basic Information, Pharmaceutical Grade Poloxamer Manufacturing Base, Sales Area and Its Competitors
Table 115. CD Formulation Pharmaceutical Grade Poloxamer Product Portfolios and Specifications
Table 116. CD Formulation Pharmaceutical Grade Poloxamer Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 117. CD Formulation Main Business
Table 118. CD Formulation Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pharmaceutical Grade Poloxamer
Figure 2. Pharmaceutical Grade Poloxamer Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pharmaceutical Grade Poloxamer Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Pharmaceutical Grade Poloxamer Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Pharmaceutical Grade Poloxamer Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Pharmaceutical Grade Poloxamer Sales Market Share by Country/Region (2025)
Figure 10. Pharmaceutical Grade Poloxamer Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Poloxamer 188
Figure 12. Product Picture of Poloxamer 407
Figure 13. Product Picture of Others
Figure 14. Global Pharmaceutical Grade Poloxamer Sales Market Share by Type in 2026
Figure 15. Global Pharmaceutical Grade Poloxamer Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of ChP
Figure 17. Product Picture of USP
Figure 18. Product Picture of EP
Figure 19. Product Picture of Others
Figure 20. Global Pharmaceutical Grade Poloxamer Sales Market Share by Pharmacopoeia Standard in 2026
Figure 21. Global Pharmaceutical Grade Poloxamer Revenue Market Share by Pharmacopoeia Standard (2021-2026)
Figure 22. Product Picture of Solid
Figure 23. Product Picture of Liquid
Figure 24. Global Pharmaceutical Grade Poloxamer Sales Market Share by Appearance in 2026
Figure 25. Global Pharmaceutical Grade Poloxamer Revenue Market Share by Appearance (2021-2026)
Figure 26. Pharmaceutical Grade Poloxamer Consumed in Injectable Formulation
Figure 27. Global Pharmaceutical Grade Poloxamer Market: Injectable Formulation (2021-2026) & (Tons)
Figure 28. Pharmaceutical Grade Poloxamer Consumed in Oral Formulation
Figure 29. Global Pharmaceutical Grade Poloxamer Market: Oral Formulation (2021-2026) & (Tons)
Figure 30. Pharmaceutical Grade Poloxamer Consumed in Topical Formulation
Figure 31. Global Pharmaceutical Grade Poloxamer Market: Topical Formulation (2021-2026) & (Tons)
Figure 32. Global Pharmaceutical Grade Poloxamer Sale Market Share by Application (2025)
Figure 33. Global Pharmaceutical Grade Poloxamer Revenue Market Share by Application in 2025
Figure 34. Pharmaceutical Grade Poloxamer Sales by Company in 2025 (Tons)
Figure 35. Global Pharmaceutical Grade Poloxamer Sales Market Share by Company in 2025
Figure 36. Pharmaceutical Grade Poloxamer Revenue by Company in 2025 ($ millions)
Figure 37. Global Pharmaceutical Grade Poloxamer Revenue Market Share by Company in 2025
Figure 38. Global Pharmaceutical Grade Poloxamer Sales Market Share by Geographic Region (2021-2026)
Figure 39. Global Pharmaceutical Grade Poloxamer Revenue Market Share by Geographic Region in 2025
Figure 40. Americas Pharmaceutical Grade Poloxamer Sales 2021-2026 (Tons)
Figure 41. Americas Pharmaceutical Grade Poloxamer Revenue 2021-2026 ($ millions)
Figure 42. APAC Pharmaceutical Grade Poloxamer Sales 2021-2026 (Tons)
Figure 43. APAC Pharmaceutical Grade Poloxamer Revenue 2021-2026 ($ millions)
Figure 44. Europe Pharmaceutical Grade Poloxamer Sales 2021-2026 (Tons)
Figure 45. Europe Pharmaceutical Grade Poloxamer Revenue 2021-2026 ($ millions)
Figure 46. Middle East & Africa Pharmaceutical Grade Poloxamer Sales 2021-2026 (Tons)
Figure 47. Middle East & Africa Pharmaceutical Grade Poloxamer Revenue 2021-2026 ($ millions)
Figure 48. Americas Pharmaceutical Grade Poloxamer Sales Market Share by Country in 2025
Figure 49. Americas Pharmaceutical Grade Poloxamer Revenue Market Share by Country (2021-2026)
Figure 50. Americas Pharmaceutical Grade Poloxamer Sales Market Share by Type (2021-2026)
Figure 51. Americas Pharmaceutical Grade Poloxamer Sales Market Share by Application (2021-2026)
Figure 52. United States Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 53. Canada Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 54. Mexico Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 55. Brazil Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 56. APAC Pharmaceutical Grade Poloxamer Sales Market Share by Region in 2025
Figure 57. APAC Pharmaceutical Grade Poloxamer Revenue Market Share by Region (2021-2026)
Figure 58. APAC Pharmaceutical Grade Poloxamer Sales Market Share by Type (2021-2026)
Figure 59. APAC Pharmaceutical Grade Poloxamer Sales Market Share by Application (2021-2026)
Figure 60. China Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 61. Japan Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 62. South Korea Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 63. Southeast Asia Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 64. India Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 65. Australia Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 66. China Taiwan Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 67. Europe Pharmaceutical Grade Poloxamer Sales Market Share by Country in 2025
Figure 68. Europe Pharmaceutical Grade Poloxamer Revenue Market Share by Country (2021-2026)
Figure 69. Europe Pharmaceutical Grade Poloxamer Sales Market Share by Type (2021-2026)
Figure 70. Europe Pharmaceutical Grade Poloxamer Sales Market Share by Application (2021-2026)
Figure 71. Germany Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 72. France Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 73. UK Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 74. Italy Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 75. Russia Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 76. Middle East & Africa Pharmaceutical Grade Poloxamer Sales Market Share by Country (2021-2026)
Figure 77. Middle East & Africa Pharmaceutical Grade Poloxamer Sales Market Share by Type (2021-2026)
Figure 78. Middle East & Africa Pharmaceutical Grade Poloxamer Sales Market Share by Application (2021-2026)
Figure 79. Egypt Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 80. South Africa Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 81. Israel Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 82. Turkey Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 83. GCC Countries Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 84. Manufacturing Cost Structure Analysis of Pharmaceutical Grade Poloxamer in 2026
Figure 85. Manufacturing Process Analysis of Pharmaceutical Grade Poloxamer
Figure 86. Industry Chain Structure of Pharmaceutical Grade Poloxamer
Figure 87. Channels of Distribution
Figure 88. Global Pharmaceutical Grade Poloxamer Sales Market Forecast by Region (2027-2032)
Figure 89. Global Pharmaceutical Grade Poloxamer Revenue Market Share Forecast by Region (2027-2032)
Figure 90. Global Pharmaceutical Grade Poloxamer Sales Market Share Forecast by Type (2027-2032)
Figure 91. Global Pharmaceutical Grade Poloxamer Revenue Market Share Forecast by Type (2027-2032)
Figure 92. Global Pharmaceutical Grade Poloxamer Sales Market Share Forecast by Application (2027-2032)
Figure 93. Global Pharmaceutical Grade Poloxamer Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Pharmaceutical Grade Poloxamer
Figure 2. Pharmaceutical Grade Poloxamer Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pharmaceutical Grade Poloxamer Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Pharmaceutical Grade Poloxamer Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Pharmaceutical Grade Poloxamer Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Pharmaceutical Grade Poloxamer Sales Market Share by Country/Region (2025)
Figure 10. Pharmaceutical Grade Poloxamer Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Poloxamer 188
Figure 12. Product Picture of Poloxamer 407
Figure 13. Product Picture of Others
Figure 14. Global Pharmaceutical Grade Poloxamer Sales Market Share by Type in 2026
Figure 15. Global Pharmaceutical Grade Poloxamer Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of ChP
Figure 17. Product Picture of USP
Figure 18. Product Picture of EP
Figure 19. Product Picture of Others
Figure 20. Global Pharmaceutical Grade Poloxamer Sales Market Share by Pharmacopoeia Standard in 2026
Figure 21. Global Pharmaceutical Grade Poloxamer Revenue Market Share by Pharmacopoeia Standard (2021-2026)
Figure 22. Product Picture of Solid
Figure 23. Product Picture of Liquid
Figure 24. Global Pharmaceutical Grade Poloxamer Sales Market Share by Appearance in 2026
Figure 25. Global Pharmaceutical Grade Poloxamer Revenue Market Share by Appearance (2021-2026)
Figure 26. Pharmaceutical Grade Poloxamer Consumed in Injectable Formulation
Figure 27. Global Pharmaceutical Grade Poloxamer Market: Injectable Formulation (2021-2026) & (Tons)
Figure 28. Pharmaceutical Grade Poloxamer Consumed in Oral Formulation
Figure 29. Global Pharmaceutical Grade Poloxamer Market: Oral Formulation (2021-2026) & (Tons)
Figure 30. Pharmaceutical Grade Poloxamer Consumed in Topical Formulation
Figure 31. Global Pharmaceutical Grade Poloxamer Market: Topical Formulation (2021-2026) & (Tons)
Figure 32. Global Pharmaceutical Grade Poloxamer Sale Market Share by Application (2025)
Figure 33. Global Pharmaceutical Grade Poloxamer Revenue Market Share by Application in 2025
Figure 34. Pharmaceutical Grade Poloxamer Sales by Company in 2025 (Tons)
Figure 35. Global Pharmaceutical Grade Poloxamer Sales Market Share by Company in 2025
Figure 36. Pharmaceutical Grade Poloxamer Revenue by Company in 2025 ($ millions)
Figure 37. Global Pharmaceutical Grade Poloxamer Revenue Market Share by Company in 2025
Figure 38. Global Pharmaceutical Grade Poloxamer Sales Market Share by Geographic Region (2021-2026)
Figure 39. Global Pharmaceutical Grade Poloxamer Revenue Market Share by Geographic Region in 2025
Figure 40. Americas Pharmaceutical Grade Poloxamer Sales 2021-2026 (Tons)
Figure 41. Americas Pharmaceutical Grade Poloxamer Revenue 2021-2026 ($ millions)
Figure 42. APAC Pharmaceutical Grade Poloxamer Sales 2021-2026 (Tons)
Figure 43. APAC Pharmaceutical Grade Poloxamer Revenue 2021-2026 ($ millions)
Figure 44. Europe Pharmaceutical Grade Poloxamer Sales 2021-2026 (Tons)
Figure 45. Europe Pharmaceutical Grade Poloxamer Revenue 2021-2026 ($ millions)
Figure 46. Middle East & Africa Pharmaceutical Grade Poloxamer Sales 2021-2026 (Tons)
Figure 47. Middle East & Africa Pharmaceutical Grade Poloxamer Revenue 2021-2026 ($ millions)
Figure 48. Americas Pharmaceutical Grade Poloxamer Sales Market Share by Country in 2025
Figure 49. Americas Pharmaceutical Grade Poloxamer Revenue Market Share by Country (2021-2026)
Figure 50. Americas Pharmaceutical Grade Poloxamer Sales Market Share by Type (2021-2026)
Figure 51. Americas Pharmaceutical Grade Poloxamer Sales Market Share by Application (2021-2026)
Figure 52. United States Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 53. Canada Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 54. Mexico Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 55. Brazil Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 56. APAC Pharmaceutical Grade Poloxamer Sales Market Share by Region in 2025
Figure 57. APAC Pharmaceutical Grade Poloxamer Revenue Market Share by Region (2021-2026)
Figure 58. APAC Pharmaceutical Grade Poloxamer Sales Market Share by Type (2021-2026)
Figure 59. APAC Pharmaceutical Grade Poloxamer Sales Market Share by Application (2021-2026)
Figure 60. China Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 61. Japan Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 62. South Korea Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 63. Southeast Asia Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 64. India Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 65. Australia Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 66. China Taiwan Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 67. Europe Pharmaceutical Grade Poloxamer Sales Market Share by Country in 2025
Figure 68. Europe Pharmaceutical Grade Poloxamer Revenue Market Share by Country (2021-2026)
Figure 69. Europe Pharmaceutical Grade Poloxamer Sales Market Share by Type (2021-2026)
Figure 70. Europe Pharmaceutical Grade Poloxamer Sales Market Share by Application (2021-2026)
Figure 71. Germany Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 72. France Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 73. UK Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 74. Italy Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 75. Russia Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 76. Middle East & Africa Pharmaceutical Grade Poloxamer Sales Market Share by Country (2021-2026)
Figure 77. Middle East & Africa Pharmaceutical Grade Poloxamer Sales Market Share by Type (2021-2026)
Figure 78. Middle East & Africa Pharmaceutical Grade Poloxamer Sales Market Share by Application (2021-2026)
Figure 79. Egypt Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 80. South Africa Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 81. Israel Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 82. Turkey Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 83. GCC Countries Pharmaceutical Grade Poloxamer Revenue Growth 2021-2026 ($ millions)
Figure 84. Manufacturing Cost Structure Analysis of Pharmaceutical Grade Poloxamer in 2026
Figure 85. Manufacturing Process Analysis of Pharmaceutical Grade Poloxamer
Figure 86. Industry Chain Structure of Pharmaceutical Grade Poloxamer
Figure 87. Channels of Distribution
Figure 88. Global Pharmaceutical Grade Poloxamer Sales Market Forecast by Region (2027-2032)
Figure 89. Global Pharmaceutical Grade Poloxamer Revenue Market Share Forecast by Region (2027-2032)
Figure 90. Global Pharmaceutical Grade Poloxamer Sales Market Share Forecast by Type (2027-2032)
Figure 91. Global Pharmaceutical Grade Poloxamer Revenue Market Share Forecast by Type (2027-2032)
Figure 92. Global Pharmaceutical Grade Poloxamer Sales Market Share Forecast by Application (2027-2032)
Figure 93. Global Pharmaceutical Grade Poloxamer Revenue Market Share Forecast by Application (2027-2032)
